← All stocks

Apyx Medical Corp

APYX Net buying
CIK 0000719135 #4192 in the set updated 22 Sep 2026
Bought (120 mo)
$253.27K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$113.40K
$0.00 on a plan · $113.40K straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
+$139.87K
+$253.27K against sales at will

By person

9 insiders · 27 transactions
0.2×

Charles D. Goodwin holds only 0.2 times base salary in stock. $101.70K of shares against $501.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Charles D. Goodwin last reported holding, valued at $1.13, the price Common Stock was last bought or sold at on the open market here, on 13 Aug 2024.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Goodwin Charles D. II
Chief Executive Officer
$241.76K (4)
+$241.76K
90,000
0.2137%
$101.70K
Hornsby Todd
Executive Vice President
$113.40K (1) scheduled
−$113.40K
40
<0.0001%
$45.20
0.0%
HILL MATTHEW C
Chief Financial Officer
$11.50K (2)
+$11.50K
7,836
0.0186%
$8.85K
MAKRIDES ANDREW
Director
624,389
1.48%
$705.56K
+1.7%
CITRONOWICZ MOSHE
Sr. V.P. of Operations
493,504
1.17%
$557.66K
+15.7%
Waldman Lawrence
Director
49,877
0.1184%
$56.36K
Geraghty Michael
Director
27,500
0.0653%
$31.07K
Swandal Craig A.
Director
17,000
0.0404%
$19.21K
Roman Shawn David
Chief Operating Officer
16,467
0.0391%
$18.61K
Insider
Date
Role
Action
Shares
Price
Amount
Waldman Lawrence
30 Jun 2026
Director
Exercised, kept indirect
12,000
$1.88
$22.56K
Roman Shawn David
15 Jun 2026
Chief Operating Officer
Exercised, kept indirect
15,000
$3.23
$48.45K
CITRONOWICZ MOSHE
15 Mar 2026
Senior Vice President
Exercised, kept
37,000
$1.80
$66.60K
Roman Shawn David
27 Jan 2026
Chief Operating Officer
Exercised, kept indirect
12,000
$1.80
$21.60K
Waldman Lawrence
12 Jul 2023
Director
Exercised, kept indirect
5,338
$2.97
$15.85K
Geraghty Michael
6 Jun 2023
Director
Exercised, kept
10,000
$2.79
$27.90K
Waldman Lawrence
11 Jul 2022
Director
Exercised, kept
24,000
$2.54
$60.96K
CITRONOWICZ MOSHE
11 Jul 2022
Sr. V.P. of Operations
Exercised, kept
30,000
$2.54
$76.20K
Geraghty Michael
6 Jul 2022
Director
Exercised, kept
4,000
$2.54
$10.16K
MAKRIDES ANDREW
5 Jul 2022
Director
Exercised, kept
30,000
$2.54
$76.20K
Waldman Lawrence
19 May 2022
Director
Exercised, kept
8,000
$2.79
$22.32K
Geraghty Michael
11 May 2022
Director
Exercised, kept
6,000
$2.79
$16.74K
Swandal Craig A.
21 Mar 2022
Director
Exercised, kept
17,000
$4.98
$84.66K
Swandal Craig A.
7 Jan 2022
Director
Exercised, kept
7,173
$9.42
$67.57K
Waldman Lawrence
8 Mar 2021
Director
Exercised, kept
5,563
$2.81
$15.63K
Geraghty Michael
5 Mar 2021
Director
Exercised, kept
7,500
$2.81
$21.08K
Swandal Craig A.
1 Oct 2019
Director
Exercised, kept
10,000
$5.30
$53.00K
Swandal Craig A.
4 Apr 2019
Director
Exercised, kept
2,000
$2.37
$4.74K
Swandal Craig A.
10 Jan 2019
Director
Exercised, kept
8,000
$5.30
$42.40K
Swandal Craig A.
10 Jan 2019
Director
Exercised, kept
10,000
$2.37
$23.70K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 766,714
History held since 27 Sep 2017